Indication
Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.
Loading your page…
Loading your page…
Adrenal Hyperplasia, Congenital
Marketing Authorisation Holder: Immedica Pharma AB
EMA Authorisation: 27/05/2021
INN: hydrocortisone
AI Drug & Interaction Analysis
Free account required
Ask Osler about Efmody: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.